Found: 7
Select item for more details and to access through your institution.
Schwere Candida-glabrata-Pankolitis und letale Aspergillus-fumigatus-Lungeninfektion vor dem Hintergrund einer Knochenmarkaplasie nach CD19-spezifischer CAR T-Zell-Therapie – ein Fallbericht.
- Published in:
- Kompass Onkologie, 2021, v. 8, n. 3, p. 159, doi. 10.1159/000518824
- By:
- Publication type:
- Article
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 259, doi. 10.1007/s00277-023-05507-9
- By:
- Publication type:
- Article
Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy - a case report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00566-7
- By:
- Publication type:
- Article
Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad135
- By:
- Publication type:
- Article
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.974029
- By:
- Publication type:
- Article
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1406, doi. 10.1007/s00259-022-06075-2
- By:
- Publication type:
- Article